David Arkowitz - May 10, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Chief Financial Officer
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
May 10, 2021
Transactions value $
-$16,116
Form type
4
Date filed
5/12/2021, 05:06 PM
Previous filing
Mar 9, 2023
Next filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Sale -$16.1K -2.23K -1% $7.23 221K May 10, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on June 1, 2018.
F2 The weighted average sale price for the transaction reported was $7.23. The shares were sold at a range of prices between $7.14 and $7.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.